Sandoz Group AG
LSE:0SAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sandoz Group AG
LSE:0SAN
|
CH |
|
Kruk SA
F:83I
|
PL |
|
S
|
Swiss Properties Invest A/S
F:SR1
|
DK |
|
R
|
Rivalry Corp
OTC:RVLCF
|
CA |
|
P
|
Persimmon PLC
F:OHP
|
UK |
|
Y
|
YPF SA
F:YPF
|
AR |
|
A
|
Alibaba Group Holding Ltd
F:AHLA
|
HK |
|
Aallon Group Oyj
F:I74
|
FI |
Intrinsic Value
Is 0SAN undervalued or overvalued?
See the intrinsic value estimate for Sandoz Group AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
0SAN looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 0SAN’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Sandoz Group Does
Sandoz Group AG makes generic medicines and biosimilars, which are lower-cost versions of brand-name drugs and complex biologic medicines after patents expire. It also supplies certain established medicines such as antibiotics and other hospital and retail pharmacy products. The company sells to wholesalers, pharmacies, hospitals, and health systems that need reliable access to medicines at lower prices.
- Headquarters
- Switzerland CH
- Employees
- 22 356
- IPO date
- Oct 4, 2023
Latest Earnings Call
- Stock, next trading day
- +1.6%
Earnings Waterfall
Sandoz Group AG
The intrinsic value for Sandoz Group AG (0SAN) under the Base Case is hidden CHF.
Compared with the current market price of 77.12 CHF, the stock appears hidden.